Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Krystal Biotech (KRYS) Return on Invested Capital (2024 - 2025)

Historic Return on Invested Capital for Krystal Biotech (KRYS) over the last 2 years, with Q4 2025 value amounting to 0.15%.

  • Krystal Biotech's Return on Invested Capital rose 800.0% to 0.15% in Q4 2025 from the same period last year, while for Dec 2025 it was 0.15%, marking a year-over-year increase of 800.0%. This contributed to the annual value of 0.16% for FY2025, which is 900.0% up from last year.
  • As of Q4 2025, Krystal Biotech's Return on Invested Capital stood at 0.15%, which was up 800.0% from 0.15% recorded in Q3 2025.
  • In the past 5 years, Krystal Biotech's Return on Invested Capital ranged from a high of 0.15% in Q3 2025 and a low of 0.08% during Q1 2024